This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://dx.doi.org/10.1111/
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q50510640
rdf:type
wikibase:Item
schema:description
articolo scientifico 2012年の論文 บทความทางวิทยาศาสตร์ 2012年學術文章 artikull shkencor artikel ilmiah מאמר מדעי мақолаи илмӣ article científic vitenskapelig artikkel 2012年学术文章 artykuł naukowy vetenskaplig artikel 2012年学术文章 artigo científico مقالة علمية نشرت في أغسطس 2012 article scientific teaduslik artikkel scienca artikolo vědecký článek article scientifique научна статия 2012年學術文章 tieteellinen artikkeli artikulong pang-agham wissenschaftlicher Artikel სამეცნიერო სტატია научни чланак scientific article published in August 2012 articol științific 2012年学术文章 bilimsel makale আগস্ট ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научни чланак naučni članak artigo científico 2012年學術文章 scientific article published in August 2012 videnskabelig artikel 2012 nî lūn-bûn vedecký článok tudományos cikk 2012年学术文章 наукова стаття, опублікована в серпні 2012 научная статья 2012년 논문 artículu científicu 2012年学术文章 vitskapeleg artikkel 2012年學術文章 bài báo khoa học artículo científico publicado en 2012 επιστημονικό άρθρο 2012年学术文章 artigo científico wetenschappelijk artikel 2012年學術文章 scientific article published in August 2012
p:P577
wds:Q50510640-5186C64A-873F-477E-B1C3-C0F72F6E80A5
wdt:P577
2012-08-01T00:00:00Z
p:P2860
wds:Q50510640-5DCE9076-0D2A-4F08-847F-DEDBB470853F wds:Q50510640-68565E03-BCF9-4D65-BB81-F14182FC6282 wds:Q50510640-82B74D64-D1C5-4D89-96F7-4F7E97AB7139 wds:Q50510640-0C1C4138-4388-415E-BC93-71CD463C8707 wds:Q50510640-1F07B13D-F559-4F5D-A76B-D4EC0B7DED5C wds:Q50510640-C994090E-A9F1-42DF-AC7E-0CBF124B0408 wds:Q50510640-CF31064F-14EE-4198-860A-FD0EED056A9F wds:Q50510640-F4102CE6-FFE6-4A69-8FAE-315623C229A0 wds:Q50510640-FB58E969-1DC6-4853-9285-0B510E5D63EC wds:Q50510640-95476A13-46F6-4C0C-8E7A-D70031B8810B wds:Q50510640-9656059A-49F3-4BAE-BCC6-32BE2F1C038E wds:Q50510640-A7DC3A39-CFB9-44CD-B422-A4E6AC4CA69B wds:Q50510640-A95E0F36-F647-43A9-BEFC-D2E3CFA1D4BF
wdt:P2860
wd:Q39572948 wd:Q46775203 wd:Q43055607 wd:Q40819435 wd:Q41740245 wd:Q51122414 wd:Q34577241 wd:Q35771817 wd:Q39802111 wd:Q36916949 wd:Q43251447 wd:Q45233765 wd:Q29615973
p:P2093
wds:Q50510640-FD3A0BB4-85BF-42D5-8C52-2C97B7FDD531 wds:Q50510640-BC0F1FB4-837E-4FA5-81B8-D933DA186FBE wds:Q50510640-82F38CCE-EBBD-41D9-BE7A-1CECA99EDBE5 wds:Q50510640-22FE909A-3160-4282-9ECA-EE46A61DF128
wdt:P2093
Steven C Zammit Bing Wang Christina Y R Tan Sih Min Tan
rdfs:label
FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
skos:prefLabel
FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
schema:name
FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
p:P50
wds:Q50510640-306F4AB4-A1DB-4176-8CF0-AC6694B04D9D wds:Q50510640-31529CA0-7F24-444D-AFA1-3B9E606A9219 wds:Q50510640-34A714CD-4D93-49C1-AA7D-C8082C94CF57 wds:Q50510640-75C9677E-411D-473E-874A-A0A1E3E4F3EE
wdt:P50
wd:Q101978886 wd:Q42690198 wd:Q82083581 wd:Q59540196
p:P1476
wds:Q50510640-ACC919D2-65F3-4A2F-A434-3C9FACB58579
wdt:P1476
FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
p:P304
wds:Q50510640-57ADECCB-4EA8-45A5-90D2-16D748C5AEC7
wdt:P304
650-656
p:P31
wds:Q50510640-F37A5449-8C5B-4D10-9CF4-2A56E1B6A74F
wdt:P31
wd:Q13442814
p:P698
wds:Q50510640-43388B37-C2AD-4073-B6C6-8CCA5926FA2A
wdtn:P698
n11:22612418
wdt:P698
22612418
p:P1433
wds:Q50510640-BE696032-CD26-48F7-A1B5-7D569AC9727F
wdt:P1433
wd:Q5133807
p:P433
wds:Q50510640-452FD523-EFBE-408F-9EF8-6757CEE1B371
p:P478
wds:Q50510640-504F1357-E1FF-4607-85BC-A25151A1779D
wdt:P433
8
wdt:P478
39
p:P356
wds:Q50510640-08CE7650-2CBF-44C8-8788-3F61F43A0027
wdtn:P356
n9:J.1440-1681.2012.05726.X
wdt:P356
10.1111/J.1440-1681.2012.05726.X